Establishes certain prescription drug data reporting requirements for hospitals.
This bill requires New Jersey hospitals to report prescription drug pricing data to the Division of Consumer Affairs. It mandates hospitals (defined as general acute care hospitals licensed under state law) to submit accurate data on drug costs, including wholesale acquisition cost, under penalty of perjury. Non-compliance could result in civil penalties starting at $10,000 for the first day of violation and increasing up to $100,000 per day. The law also authorizes audits and corrective action plans for reporting deficiencies. This directly affects hospitals and other entities required to report drug pricing data under the amended statute.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026
Last action Jan 13, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced, Referred to Assembly Health Infrastructure Committee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Dan Hutchison
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 3265
Scope: NJ
Hi! I can help you understand A 3265. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline